It has been suggested that, during heart failure, when the levels of circulating AVP are elevated, the inhibition of G protein-coupled receptor kinase 2 (GRK2) can potentially exacerbate negative V1aR-mediated effects by preventing receptor desensitization and augmenting Gαq protein-dependent signaling [149,150]. Here, GRK2 is linked to heart failure.